CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Iovance hits highest since 2024 as analysts cheer guidance raise

EarningsPositive
AI Analysis

Summary

Iovance Biotherapeutics reached its highest stock price since 2024 following a guidance raise that was positively received by analysts.

Financial Highlights

Guidance

raised

Importance:5/10
Sentiment:
0.70
guidancestock_priceanalyst_commentary
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on September 29, 2026 6:47 PM

Read Original